Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000148928 | SCV001467757 | pathogenic | Intellectual disability, autosomal recessive 46 | 2020-12-03 | criteria provided, single submitter | clinical testing | Variant summary: NDST1 c.1831G>A (p.Gly611Ser) results in a non-conservative amino acid change located in the Sulfotransferase domain (IPR000863) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8e-06 in 250738 control chromosomes (gnomAD). c.1831G>A has been reported in the literature as a homozygous mutation in multiple individuals affected with intellectual disability (e.g. Reuter_2014, Martinez_2017). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One ClinVar submitter (evaluation after 2014) cites the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. |
Laboratoire de Génétique Moléculaire, |
RCV002279948 | SCV002568838 | pathogenic | not provided | criteria provided, single submitter | clinical testing | ||
MGZ Medical Genetics Center | RCV000148928 | SCV002581582 | likely pathogenic | Intellectual disability, autosomal recessive 46 | 2022-03-11 | criteria provided, single submitter | clinical testing | |
Human Genetics Bochum, |
RCV002463649 | SCV002758631 | likely pathogenic | Global developmental delay | 2022-02-16 | criteria provided, single submitter | clinical testing | ACMG criteria used to clasify this variant: PS4, PM1, PM2_SUP, PP3 |
Labcorp Genetics |
RCV002279948 | SCV003439241 | likely pathogenic | not provided | 2023-03-23 | criteria provided, single submitter | clinical testing | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt NDST1 protein function. ClinVar contains an entry for this variant (Variation ID: 161412). This missense change has been observed in individuals with clinical features of intellectual disability (PMID: 25125150, 27620904; Invitae). This variant is present in population databases (rs606231459, gnomAD 0.002%). This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 611 of the NDST1 protein (p.Gly611Ser). |
Institute of Human Genetics, |
RCV003128390 | SCV003804820 | likely pathogenic | See cases | 2022-10-20 | criteria provided, single submitter | clinical testing | ACMG categories: PM2,PM3,PP3,PP5 |
Revvity Omics, |
RCV000148928 | SCV003814499 | likely pathogenic | Intellectual disability, autosomal recessive 46 | 2022-05-16 | criteria provided, single submitter | clinical testing | |
Gene |
RCV002279948 | SCV003935846 | likely pathogenic | not provided | 2023-06-21 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25125150, 31589614, 27870114, 27620904, 35887114) |
Ce |
RCV002279948 | SCV004701944 | likely pathogenic | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | NDST1: PM1, PM2, PM3, PP3 |
Equipe Genetique des Anomalies du Developpement, |
RCV000148928 | SCV005016493 | pathogenic | Intellectual disability, autosomal recessive 46 | 2023-11-02 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000148928 | SCV000195816 | pathogenic | Intellectual disability, autosomal recessive 46 | 2014-11-01 | no assertion criteria provided | literature only |